Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation
出版年份 2012 全文链接
标题
Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation
作者
关键词
-
出版物
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Volume 25, Issue 2, Pages 180-186
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2012-10-09
DOI
10.1097/meg.0b013e328359e550
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation
- (2012) Arndt Weinmann et al. DIGESTIVE AND LIVER DISEASE
- Liver transplantation for hepatocellular carcinoma: an update
- (2012) Ali Zarrinpar et al. Hepatobiliary & Pancreatic Diseases International
- Fatal gastric bleeding during sorafenib treatment for hepatocellular carcinoma recurrence after liver transplantation
- (2011) Andrea Mancuso et al. DIGESTIVE AND LIVER DISEASE
- Criteria for liver transplantation for HCC: What should the limits be?
- (2011) Mauricio F. Silva et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation
- (2011) Carlos Gomez-Martin et al. LIVER TRANSPLANTATION
- Everolimus Augments the Effects of Sorafenib in a Syngeneic Orthotopic Model of Hepatocellular Carcinoma
- (2011) A.-C. Piguet et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation
- (2010) Wei-feng Tan et al. ACTA PHARMACOLOGICA SINICA
- Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation
- (2010) D. H. Yoon et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Feasibility of 125I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma
- (2010) Chuanxing Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle
- (2010) Sherrie Bhoori et al. JOURNAL OF HEPATOLOGY
- Safety and Feasibility of Using Sorafenib in Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation
- (2010) Richard Kim et al. ONCOLOGY
- Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
- (2010) Riccardo Lencioni et al. SEMINARS IN LIVER DISEASE
- Sorafenib-Induced Severe Acute Hepatitis in a Stable Liver Transplant Recipient
- (2010) Uta Herden et al. TRANSPLANTATION
- Management of Hepatocellular Carcinoma Recurrence After Liver Transplantation
- (2010) A. Valdivieso et al. TRANSPLANTATION PROCEEDINGS
- Sirolimus plus sorafenib in treating HCC recurrence after liver transplantation: A case report
- (2010) Yubao Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Apparent Remission of a Solitary Metastatic Pulmonary Lesion in a Liver Transplant Recipient Treated with Sorafenib
- (2009) M. Yeganeh et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation
- (2009) A. Hollebecque et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma
- (2009) Christian Toso et al. HEPATOLOGY
- Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
- (2009) Pippa Newell et al. JOURNAL OF HEPATOLOGY
- Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials
- (2009) Youjin Je et al. LANCET ONCOLOGY
- Molecularly targeted therapy for hepatocellular carcinoma
- (2008) Shinji Tanaka et al. CANCER SCIENCE
- Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma
- (2008) Z. Wang et al. CLINICAL CANCER RESEARCH
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation
- (2008) Jeong-Ok Lee et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. JNCI-Journal of the National Cancer Institute
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
- (2008) Michael A. Zimmerman et al. LIVER TRANSPLANTATION
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sirolimus-Based Immunosuppression Therapy in Liver Transplantation for Patients With Hepatocellular Carcinoma Exceeding the Milan Criteria
- (2008) J. Zhou et al. TRANSPLANTATION PROCEEDINGS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started